← Product Code [GKL](/submissions/HE/subpart-f%E2%80%94automated-and-semi-automated-hematology-devices/GKL) · K991070 # COULTER Z2 ANALYZER (K991070) _Coulter Corp. · GKL · May 11, 1999 · Hematology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HE/subpart-f%E2%80%94automated-and-semi-automated-hematology-devices/GKL/K991070 ## Device Facts - **Applicant:** Coulter Corp. - **Product Code:** [GKL](/submissions/HE/subpart-f%E2%80%94automated-and-semi-automated-hematology-devices/GKL.md) - **Decision Date:** May 11, 1999 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 864.5200 - **Device Class:** Class 2 - **Review Panel:** Hematology ## Indications for Use The COULTER® Z2 instrument may be used for in vitro diagnostic use to determine the human erythrocyte concentration (Red Cell Count or RBC), leukocyte concentration (White Cell Count or WBC) and thrombocyte concentration (Platelet Count or Plt). In addition, the COULTER Z2 also provides the mean erythrocyte volume (Mean Cell Volume or MCV) and the mean thrombocyte volume (Mean Platelet Volume or MPV). ## Device Story The COULTER Z2 is a semi-automated, dual-threshold particle counter and sizer for biological and industrial use. It processes blood samples suspended in an aqueous electrolyte solution. The device utilizes the Coulter principle for enumeration and sizing of particles (1 to 120 µm diameter). It employs a hydraulic metering station and surface-mount electronics. The operator interacts via a detachable keyboard to initiate counts and view channelized size distribution data on-screen or via printout. The device performs coincidence correction to adjust for particle concentration. It provides clinicians with quantitative counts and volume metrics (RBC, WBC, PLT, MCV, MPV) to assist in hematological assessment. The system requires manual sample dilution and manual probe cleaning. ## Clinical Evidence Bench testing only. Accuracy and imprecision analysis performed on 31 samples. Accuracy metrics (mean difference, SD, % difference, correlation coefficient) reported for RBC, MCV, PLT, and MPV. Imprecision (reproducibility) reported as CV% for RBC (2.06%), PLT (2.95%), MPV (1.48%), and MCV (0.87%). ## Technological Characteristics Dual-threshold particle counter; utilizes Coulter principle (electrical impedance); measures particles 1-120 µm; surface-mount technology; hydraulic metering station; detachable keyboard interface; requires external dilutor for predilute samples; reagent system (isotonic diluent, lytic reagent, cleaner). ## Regulatory Identification An automated cell counter is a fully-automated or semi-automated device used to count red blood cells, white blood cells, or blood platelets using a sample of the patient's peripheral blood (blood circulating in one of the body's extremities, such as the arm). These devices may also measure hemoglobin or hematocrit and may also calculate or measure one or more of the red cell indices (the erythrocyte mean corpuscular volume, the mean corpuscular hemoglobin, or the mean corpuscular hemoglobin concentration). These devices may use either an electronic particle counting method or an optical counting method. ## Predicate Devices - COULTER® Z1 Analyzer ([K952308](/device/K952308.md)) - COULTER® STKS Analyzer ([K885093](/device/K885093.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ # Summary of Safety and Effectiveness COULTER® Z2 Analyzer ### Submitted By: 1.0 Tom English Manager, Premarket Product Regulatory Compliance Coulter Corporation 11800 SW 147 Avenue, MC 31-B06 Miami, FL 33196 Telephone: (305) 380-4331 FAX: (305) 380-3618 ### 2.0 Date Submitted: March 30, 1999 ### 3.0 Device Names: - 3.1 Proprietary Name(s): COULTER® Z2 Analyzer - 3.2. Classification Name(s): Automated cell counter (21 CFR §864.5200) ### Predicate Device(s): 4.0 COULTER® Z1 Analyzer COULTER® STKS Analyzer {1}------------------------------------------------ #### 5.0 Description COULTER Z2 has the same technological characteristics and is substantially equivalent to the COULTER® STKS analyzer that was cleared by 510(k) K885093 cleared on Dec. 28, 1988. The COULTER Z2 is the same device as the COULTER® Z1, cleared by 510(k) K952308 on October 6, 1995 except for the measurement of two additional parameters, Mean Cell Volume (MCV) and Mean Platelet Volume (MPV) and the ability to provide the operator with on-screen/printed graphs of channelized size distribution data. The COULTER Z2 is a general purpose dual threshold particle counter and sizer designed to count and size particles, suspended in an aqueous electrolyte solution, within the range of 1 to 120 um equivalent spherical diameter. The instrument is designed for both biological and industrial use. As with the predicate devices, the COULTER Z2 utilizes the Coulter principle for the enumeration and sizing of blood cells. The same reagent system, composed of an isotonic diluent, lytic reagent to lyse red blood cells for WBC measurement and instrument cleaner, is used on COULTER STKS, Z1, and Z2 instruments. The COULTER STKS, Z1, and Z2 instruments are capable of determining the human erythrocyte concentration (Red Cell Count or RBC), leukocyte concentration (White Cell Count or WBC) and thrombocyte concentration (Platelet Count or Plt). In addition, like the COULTER STKS, the COULTER Z2 also provides the mean erythrocyte volume (Mean Cell Volume or MCV) and the mean thrombocyte volume (Mean Platelet Volume or MPV). Both the COULTER Z1 and the Z2 instruments contain a hydraulic metering station built into the electronics main unit, measure a restricted range of particle {2}------------------------------------------------ sizes (within the range 1 to 120 µM) and utilize surface-mount technology. Operator-adjustable controls are accessible by means of a keyboard data terminal. #### 6.0. Intended use: The COULTER® Z Series Analyzers is a semi-automated device that may be used for in vitro diagnostic use to determine the human erythrocyte concentration (Red Cell Count or RBC), leukocyte concentration (White Cell Count or WBC) and thrombocyte concentration (Platelet Count or Pit). In addition, the COULTER Z2 also provides the mean erythrocyte volume (Mean Cell Volume or MCV) and the mean thrombocyte volume (Mean Platelet Volume or MPV). This submission provides information concerning the safety and effectiveness principally of the two parameters added to the instrument. #### 7.0 Comparison to Predicate(s): The following tables outline the basic similarities and differences between the Z2 and the predicate devices. {3}------------------------------------------------ ## SIMILARITIES to the PREDICATES | COULTER® Z2 | COULTER® Z1 | COULTER® STKS | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Utilizes the Coulter principle for enumeration
and sizing of blood cells. | Utilizes the Coulter principle for enumeration
and sizing of blood cells. | Utilizes the Coulter principle for enumeration
and sizing of blood cells. | | Reagent system includes an isotonic diluent,
lytic reagent and instrument cleaner. | Reagent system includes an isotonic diluent,
lytic reagent and instrument cleaner. | Reagent system includes an isotonic diluent,
lytic reagent and instrument cleaner. | | Ability to print sample results. | Ability to print sample results. | Ability to print sample results. | | Uses coincidence correction. The frequency
of coincidence is a statistically predictable
function of particle concentration and is
corrected by the instrument. | Uses coincidence correction. The frequency
of coincidence is a statistically predictable
function of particle concentration and is
corrected by the instrument. | Uses coincidence correction. The frequency
of coincidence is a statistically predictable
function of particle concentration and is
corrected by the instrument. | | The ability to provide the operator with on-
screen/printed graphs of channelized size
distribution data. | See DIFFERENCES table | The ability to provide the operator with on-
screen/printed graphs of channelized size
distribution data. | | Separate measurement of RBC, WBC and PLT
is required. | Separate measurement of RBC, WBC and PLT
is required. | See DIFFERENCES table | | Uses a single aperture each for WBC and
RBC counting and sizing. | Uses a single aperture each for WBC and
RBC counting and sizing. | See DIFFERENCES table | | No ability to store data. | No ability to store data. | See DIFFERENCES table | | Automated Calibration calculation but operator
intervention required for Control calculations. | Automated Calibration calculation but operator
intervention required for Control calculations. | See DIFFERENCES table | | Sample probe requires manually cleaning | Sample probe requires manually cleaning | See DIFFERENCES table | | Uses detachable keypad for operator
interface. | Uses detachable keypad for operator
interface. | See DIFFERENCES table. | | System does not measure hemoglobin | System does not measure hemoglobin | See DIFFERENCES table | | Requires external dilutor to supply the proper
volume of diluent for predilute samples. | Requires external dilutor to supply the proper
volume of diluent for predilute samples. | See DIFFERENCES table | | | | | | COULTER® Z2 | COULTER® Z1 | COULTER® STKS | | Can be used For In Vitro Diagnostic Use for
Red Blood Cell Count (RBC), White Blood Cell
Count (RBC), Platelet (Plt), Mean Cell Volume
(MCV), Mean Platelet Volume (MPV). | Can be used For In Vitro Diagnostic Use for
Red Blood Cell Count (RBC), White Blood Cell
Count(WBC), Platelet (Plt),. Does not measure
Mean Cell Volume (MCV), Mean Platelet
Volume. | Can be used For In Vitro Diagnostic Use for
Red Blood Cell Count (RBC), White Blood Cell
Count (WBC), Platelet (Plt), Mean Cell Volume
(MCV), Mean Platelet Volume (MPV). Other
parameters include a five-part leukocyte
differential count, hemoglobin, hematocrit,
mean cell hemoglobin, mean cell hemoglobin
concentration and red cell distribution width.
See SIMILARITIES table | | The ability to provide the operator with on-
screen/printed graphs of channelized size
distribution data. | No channelizing capability | See SIMILARITIES table | | Manual dilution of blood samples. | See SIMILARITIES table | Automated dilution of blood samples. | | Uses a single aperture each for WBC and RBC
counting and sizing. | See SIMILARITIES table | Uses three apertures each for WBC and RBC
counting and sizing. | | System does not measure hemoglobin | See SIMILARITIES table | The system uses the lysed WBC dilution to
measure Hgb in the WBC bath. A beam of
incandescent light passes through the WBC
bath and then through a 525-nm optical filter
and is measured by a photodiode. | | No ability to store data. | See SIMILARITIES table | Ability to store data. | | Requires external dilutor to supply the proper
volume of diluent for predilute samples. | See SIMILARITIES table | Ability to dispense the proper volume of diluent
for predilute samples. | | Automated Calibration calculation but operator
intervention required for Control calculations. | See SIMILARITIES table | Automated Calibration and Control
calculations. | | Uses detachable keypad for operator interface. | See SIMILARITIES table | Uses Universal Icons for operator interface. | | Sample probe requires manually cleaning | See SIMILARITIES table | Automated, self-cleaning probe. | | Separate mesurement of RBC, WBC and PLT
is required. | See SIMILARITIES table | Simultaneous measurement of all parameters. | {4}------------------------------------------------ . ### DIFFERENCES from the PREDICATES : {5}------------------------------------------------ ### 8.0 Summary of Performance Data: The data in the Premarket Notification on safety and effectiveness supports a finding of substantial equivalence to hematology analyzers already in commercial distribution. Equivalence is demonstrated through compared sample accuracy and imprecision results. | PARAMETER | UNITS | MEAN | SD | CV% | |-----------|----------------|-------|-------|------| | RBC | X 106 cells/µL | 4.77 | .0981 | 2.06 | | PLT | x 103 cells/µL | 153.8 | 4.54 | 2.95 | | MPV | fL | 7.99 | 0.12 | 1.48 | | MCV | fL | 83.14 | 0.73 | 0.87 | ### COULTER Z2 Analyzer Imprecision Analysis by Reproducibility ### COULTER Z2 Analyzer ACCURACY ANALYSIS: COMPARED SAMPLES | PARAMETER | UNITS | N | POP.
MIN | POP.
MAX | MEAN
DIFF. | SD | MEAN
%
DIFF | CORR
COEFF | |-----------|-------------------|----|-------------|-------------|---------------|-------|-------------------|---------------| | RBC | x 106
cells/µL | 31 | 3.50 | 6.02 | 0.16 | 0.24 | 3.51 | 0.90 | | MCV | fL | 31 | 78.00 | 97.46 | 0.54 | 2.7 | 0.65 | 0.82 | | PLT | x 103
cells/µL | 31 | 134 | 483 | 56.23 | 50.09 | 23.13 | 0.82 | | MPV | FL | 31 | 7.15 | 11.27 | 0.55 | 0.43 | 6.52 | 0.89 | {6}------------------------------------------------ Image /page/6/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo features a stylized abstract image of an eagle or bird with three curved lines representing its wings or feathers. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES 'USA'" is arranged in a circular fashion around the bird image. MAY 1 1 1999 Food and Drug Administration 2098 Gaither Road Rockville MD 20850 Mr. Thomas J. English Manager, Premarket Product Regulatory Compliance Coulter Corporation 11800 SW 147 Avenue, MC 31-B06 Miami, Florida 33196 Re: K991070 Trade Name: COULTER® Z2 Analyzer Regulatory Class: II Product Code: GKL Dated: March 30, 1999 Received: March 31, 1999 Dear Mr. English: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {7}------------------------------------------------ Page 2 Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88), this device may require a CLIA complexity categorization. To determine if it does, you should contact the Centers for Disease Control and Prevention (CDC) at (770) 488-7655. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours, Steven Dutman Steven I. Gutman, M.D, M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {8}------------------------------------------------ # INTENDED USE STATEMENT K991070 FO BE ASSIGNED 510(k) Number (if known): Device Name: COULTER® Z2 Analyzer ### Intended Use: The COULTER® Z2 instrument may be used for in vitro diagnostic use to determine the human erythrocyte concentration (Red Cell Count or RBC), leukocyte concentration (White Cell Count or WBC) and thrombocyte concentration (Platelet Count or Plt). In addition, the COULTER Z2 also provides the mean erythrocyte volume (Mean Cell Volume or MCV) and the mean thrombocyte volume (Mean Platelet Volume or MPV). ## 21 CFR 864.5200 Automated cell counter An automated cell counter is a fully-automated or semi-automated device used to count red blood cells, white blood cells, or blood platelets using a sample of the patients peripheral blood (blood circulating in one of the body's extremities, such as the arm). These devices may also measure hemoglobin or hematocrit and may also calculate or measure one or more of the red cell indices (the erythrocyte mean corpuscular volume, the mean corpuscular hemoglobin, or the mean corpuscular hemoglobin concentration). These devices may use either an electronic particle counting method or an optical counting method. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Peter E. Malins Division Sign-Off) Division of Clinical Laboratory De 510(k) Number **Prescription Use** (Per 21 CFR 801.109) OR Over-The-Counter Use (Optional Form 1-2-96) --- **Source:** [https://fda.innolitics.com/submissions/HE/subpart-f%E2%80%94automated-and-semi-automated-hematology-devices/GKL/K991070](https://fda.innolitics.com/submissions/HE/subpart-f%E2%80%94automated-and-semi-automated-hematology-devices/GKL/K991070) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com